Estrogen-mediated immunosuppression in autoimmune diseases

Inflammation Research

Volumn 47, Issue 7, 1998, Pages 290-301

  Jansson, L ^a   Holmdahl, R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Estrogen; Experimental models; Gender

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ANIMALS; AUTOIMMUNE DISEASES; ESTROGENS; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; PREGNANCY; RECEPTORS, ESTROGEN; SEX FACTORS;

EID: 0031854357     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050332     Document Type: Review

References (177)

1. Butterworth M, McClellan B, Allansmith M. Influence of sex on immunoglobulin levels. Nature 1967;214:1224-5.
2. Eidinger D, Garrett TJ. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J Exp Med 1972;136:1098-116.
3. Balchelor JR, Chapman BA. The influence of sex upon antibody response to an incompatible tumor. Immunology 1965;9:553-64.
4. Graff RJ, Lappe MA, Snell GD. The influence of the gonads and adrenal glands on the immune response to skin grafts. Transplantation 1969;7:105-11.
5. Krzych U, Strausser HR, Bressler JP, Goldstein AL. Effects of sex hormones on some T and B cell functions, evidenced by differential immune expression between male and female mice and cyclic pattern of immune responsiveness during the estrous cycle in female mice. Am J Reprod Immunol 1981; 1:73-7.
6. Grossman CJ, Roselle GA, Mendenhall CL. Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol 1991;40: 649-59.
7. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988;31:973-8.
8. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16α-hydroxylering of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.
9. Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991;50:343-6.
10. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994;54:1-17.
11. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994;1:219-29.
12. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989;32:15-21.
13. Hillert J, Olerup O. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype. Neurology 1993;43:163-8.
14. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes inellitus. Nature 1987;329:599-604.
15. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
16. Holt I, Cooper RG, Denton J, Meager A, Hopkins SJ. Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol 1992;31:725-33.
17. Carson DA, Chen PP, Fox RI, Kipps TJ, Jirik F, Goldfien RD, et al. Rheumatoid factor and immune networks. Ann Rev Immunol 1987;5:109-26.
18. Lahita RG. Sex steroids and the rheumatic diseases. Arthritis Rheum 1985;28:121-6.
19. Øslenson M, Aune B, Hushy G. Effects of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983;12:69-72.
20. Holmdahl R, Rubin K, Klareskog L, Denker L, Gustafson G, Larsson E. Appearance of different lymphoid cells in synovial tissue and in peripheral blood during the course of collagen II-induced arthritis in rats. Scand J Immunol 1985;21:197-204.
21. Holmdahl R, Nordling C, Rubin K, Tarkowski A, Klareskog L. Generation of monoclonal rheumatoid factors alter immunization with collagen II - anti collagen II immune complexes. Scand J Immunol 1986;24:197-203.
22. Klareskog L, Holmdahl R, Larsson E, Wigzell H. Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol 1983;51:117-25.
23. Svensson L, Jirbolt J, Holmdahl R, Jansson L. B-cell deficient mice do not develop type II collagen induced arthritis. Clin Exp Immunol 1997;111:521-7.
24. Jansson L, Mattsson A, Mattsson R, Holmdahl R. Estrogen induced suppression of collagen arthritis. V: Physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T cell mediated immunity and stimulates polyclonal B cell activity. J Autoimmun 1990;3:257-70.
25. Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982;155:1-16.
26. Holmdahl R, Jansson L, Gullberg D, Rubin K, Forsberg PO, Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol 1985;62:639-46.
27. Holmdahl R, Jansson L, Andersson M. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 1986;29:1501-9.
28. Waites GT, Whyte A. Effect of pregnancy on collagen-induced arthritis in mice. Clin Exp Immunol 1987;67:467-76.
29. Whyte A, Williams RO. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988;31:927-9.
30. Mattsson R, Mattsson A, Holmdahl R, Whyte A, Rook GAW. Maintained pregnancy levels of estrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol 1991;85:41-7.
31. Holmdahl R, Jansson L, Meyerson B, Klareskog E. Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/I mice reduces the severity and incidence of arthritis and decrease the anti-type II collagen immune response. Clin Exp Immunol 1987;70:372-8.
32. Maurtiz N-J, Holmdahl R, Jonsson R, Van Der Meide P, Scheynius A, Klareskog L. Treatment with gINF triggers onset of collagen arthritis in mice. Arthritis Rheum 1988;31:1297-1304.
33. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinent human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993;151:6602-7.
34. Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor-beta. Clin Exp Immunol 1992;89:244-50.
35. Wooley PH, Whalen JD, Chapman DL, Berger AE, Aspar DG, Richard KA. The effect of an interleukin-1 receptor antagonist protein on type II collagen and antigen-induced arthritis in mice. Arthritis Rheum 1990;33:S 20.
36. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998;187:461-8.
37. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-9.
38. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
39. Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C. The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992;19:466-71.
40. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990;346:183-6.
41. Holmdahl R, Jirholt J, Jansson L, Sundvall M. Genetic Analysis of Murine Models of Multiple Sclerosis. In: Dragani TA, editor. Human Polygenic Diseases: Animal models. Amsterdam: Harwood Academic Publishers, 1998: 131-46.
42. Sundvall M, Jirholt J, Yang H-T, Jansson L, Engström Å, Pettersson U, et al. Identification of loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis in mice. Nature Genetics 1995;10:313-7.
43. 1. Eur J Immunol 1991;21:693-9.
44. Ben-Nun A, Werkele H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981;11: 195-9.
45. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996;184:2271-8.
46. Myers KJ, Sprent J, Dougherty JP, Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 1992;41:1-8.
47. Jansson L, Olsson T, Holmdahl R. Estrogen induces potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 1994; 53: 203-7.
48. Trooster WJ, Teelken AW, Kampinga J, Loof JG, Nieuwenhuis P, Minderhoud JM. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: An immunological study in the Lewis rat. Int Arch Immunol 1993;102:133-40.
49. Abramsky O, Lubetski-Korn I, Evron S, Brenner T. Suppressive effect of pregnancy on MS and EAE. Prog Clin Biol Res 1984;146:399-406.
50. Brenner T, Shmuel E, Abramsky O. Effect of experimental autoimmune encephalomyelitis on pregnancy. Studies in rabbits and rats. Isr J Med Sci 1991;181-5.
51. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: An experimental model of arthritis. J Exp Med 1977;146:857-68.
52. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
53. Olitsky PK, Yager RH. Experimental dissiminated encephalomyelitis in white mice. J Exp Med 1949;90:213-23.
54. Dixon FJ, Andrews BS, Eisenberg RA, McConahey PJ, Theofilopoulus AN, Wilson CB. Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum 1978;21:S64-S67.
55. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-90.
56. Murgita RA. The immunosuppressive role of alpha-feto protein during pregnancy. Scand J Immunol 1976;5:1003.
57. Evron S, Brenner T, Abramsky O. Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am J Reprod Immunol 1984;5: 109-13.
58. Nicholas NS, Panayi GS. Rheumatoid arthritis and pregnancy. Clin Exp Rheumatol 1988;6:179-182.
59. Soos JM, Subramaniam PS, Hobeika AC, Schiffenbauer J, Johnson HM. The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 1995;155:2747-53.
60. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D. Progesterone and the maintenance of pregnancy: Is progesterone nature's immunosuppressant? Ann NY Acad Sci 1977; 286:3384.
61. Lahita RG. The effects of sex hormones on the immune system in pregnancy. Am J Reprod Immunol 1992;28:136-7.
62. Eriksson L, Edén S, Holst J, Lindstedt G, von Schoultz B. Diurnal variations in thyrotropin, prolactin and cortisol during human pregnancy. Gynecol Obstet Invest 1989;27:78-83.
63. Mattsson R, Mattsson A, Holmdahl R, Scheynius A, Meide PVD. In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of MHC class I and II molecules in uterus and decidua bul not in extra-embryonic tissues. Biol Reprod 1992;46:1176-86.
64. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomena? Immunol Today 1993;14:353-6.
65. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-82.
66. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995;270:630-3.
67. Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976;27:922-6.
68. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrosis and interim heat hydarthrosis. Mayo Clin Proc 1938;13:161-7.
69. Hutchinson M. Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:1043-5.
70. Tincani A, Balestrieri G, Faden D, DiMario C. Systemic lupus erythematosus in pregnancy. Lancet 1991;338:756-7.
71. Mund A, Simson J, Rothfield N. Effect of pregnancy in course of systemic lupus erythematosus. JAMA 1963;183:109-12.
72. Alekberova Z, Kosheleva N. Lupus and pregnancy in systemic lupus erythematosus (SLE). Am J Reprod Immunol 1992;28: 288.
73. Hirahara F, Wooley PH, Luthra HS, Coulam CB, Griffiths MM, David CS. Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. Am J Reprod Immunol 1986;11:44-54.
74. Jansson L, Holmdahl R. Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reprod Immunol 1989;15:141-50.
75. Mattson R, Mattsson A, Hansson I, Holmdahl R, Rook GAW, Whyte A. Increased levels of prolactin during, but not after, the immunisation with rat collagen II enhances the course of arthritis in DBA/1 mice. Autoimmunity 1992;11:163-70.
76. Berzi I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 1984;27:682-6.
77. Franks S. Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci 1983;65: 457-62.
78. Nagy E, Berezi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptin. Immunopharmacology 1983;6: 231-43.
79. Murphy WJ, Durum SK, Longo DL. Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med 1993;178:231-6.
80. Vandenbroucke JP, Witteman JCM, Valkenburg HA, Boersma JW, Cats A, Festen JJM, et al. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA 1986;255:1299-1303.
81. Bijlsma JW, J., Huber-Bruning O, Thijssen JHH. Effect of oestrogen treatment on clinical and laboratory manifestation of rheumatoid arthritis. Ann Rheum Dis 1987;46:777-9.
82. van Zehen D, Hazes JMW, Vandenhroueke JP, Dijkmans BAC, Cats A. Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum 1990;33: 1462-5.
83. Hazes JMW, Dijkmans BAC, Vandenbrouke JP, Cats A. Oral contraceptive treatment for rheumatoid arthritis: An open study in 10 female patients. Br J Rheumatol 1989;28 Suppl:28-30.
84. Hernandez-Avila M, Liang MH, Willett WC, Stamper MJ, Colditz GA, Rosner B, et al. Exogeneous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 1990;33:947-53.
85. Latman NS. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med 1983;74:957-60.
86. Arnason BG, Richman DP. Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 1969;21: 103-8.
87. MacDonald AG, Murphy EA, Capell HA, Bankowska UZ, Ralston SH. Effect of hormone replacement therapy in rheumatoid arthritis: A double blind placebo-controlled study. Ann Rheum Dis 1994;53:54-7.
88. Hall GM, Daniels M, Huskinsson EC, Spector TD. A randomised controlled trial of the effect of hormone replacement therapy on the disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 1994;53:112-6.
89. Cutolo M, Balleari E, Accardo S, Samanta E, Cimmino M, Giusti M, et al. Preliminary results of serum androgen level in men with rheumatoid arthritis. Arthritis Rheum 1984;27:958-9.
90. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status of male patients with rheumatoid arthritis: Evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988;31:1314-7.
91. Cutolo M, Balleari E, Guisti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
92. Bruot BC, Clemens JW. Regulation of testosterone production in the adjuvant-induced arthritic rat. J Andrology 1992;13: 87-92.
93. Da Silva JA. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann Rheum Dis 1995;54:6-16.
94. Larsson P, Holmdahl R. Estrogen induced suppression of collagen arthritis. II. Treatment of rats suppresses development of arthritis but does not affect the anti-type II collagen humoral response. Scand J Immunol 1987;27:579-83.
95. Holmdahl R, Vingsbo C, Hedrich H, Karlsson M, Kvick C, Goldschmidt T, et al. Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompalibility complex DQ-like molecules. Eur J Immunol 1992;22:419-24.
96. Jansson L, Holmdahl R. Oestrogen induced suppression of collagen arthritis. VI: 17 beta oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes. Clin Exp Immunol 1992;89:446-51.
97. Bebo BF Jr, Vandenbark AA, Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res 1996;45:680-9.
98. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: A cohort study. Acta Neurol Scand 1991;84:403-6.
99. Roubinian JR, Talal N, Greespan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti nucleic acid antibodies, and glomerulunephritis in NZB/NZW F1 mice. J Exp Med 1978;147:1568-83.
100. Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel WA, Smathers PA, et al. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 1979;22:1171-6.
101. Yocum MW, Grossman J, Waterhouse C, Abraham GN, May AG, Condemi JJ. Monozygotic twins discordant tor systemic lupus erythematosus. Arthritis Rheum 1975;18:193-9.
102. Carlstein H, Nilsson N, Jonsson R, Bäckman K, Holmdahl R, Tarkowski A. Estrogen accelerates immune complex glomerulonephritis hut ameliorates T cell mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr miee. Cell Immunol 1992;144:190-202.
103. Walker SH, McMurray RW, Besch-Williford CL, Keisler DH. Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand black × New Zealand white mice treated with ethinyl estradiol and 17β estradiol. Arthritis Rheum 1992;35:1387-92.
104. Cohen JHM, Danel L, Cordier G, Saez S, Revillard J-P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol 1983;131:2767-71.
105. Stimson WH. Oestrogen and human T lymphocytes: Presence of specific receptors in the T suppressor/cytotoxic subset. Scand J Immunol 1988;28:345-50.
106. Gulshan S, McCruden AB, Stimson WH. Oestrogen receptors in macrophages. Scand J Immunol 1990;31:691-7.
107. Nicol T, Bilbey DLJ, Charles LM, Cordingley JL, Vernon-Roberts B. Oestrogen: The natural stimulant of body defence. J Endocronol 1964;30:277-91.
108. Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 1993;178: 1507-15.
109. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LÅ. Oestrogen is a potent disease acclerator in SLE prone MRL lpr/lpr mice. Clin Exp Immunol 1990;80:467-73.
110. Vernon-Roberts B. The effects of steroid hormones on macrophage function. Int Rev Cytol 1969;25:131-58.
111. Nilsson N, Carlsten H. Estrogen induces suppression of Natural Killer cell cytotoxicity and augmentation of B cell activation. Cell Immunol 1994;158:131-9.
112. Pfeifer RW, Patterson RM. Modulation of nonspecific cell-mediated growth inhibition by estrogen metabolites. Immunopharmacology 1985;10:127-35.
113. Okuyama R, Abo T, Seki S, Ohteki T, Sugiura K, Kusumi A, et al. Estrogen administration activates extrathymic T cell differentiation in the liver. J Exp Med 1992;175:661-9.
114. Griffith JS, Jensen SM, Lunceford JK, Kahn MW, Zheng Y, Falase EA, et al. Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. Am J Pathol 1997; 150:2223-30.
115. Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 1995;155:3409-17.
116. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994;368:237-9.
117. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, et al. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 1997;99:2429-37.
118. Viselli SM, Stanziale S, Shults K, Kovacs WJ, Olsen NJ. Castration alters peripheral immune function in normal male mice. Immunology 1995;84:337-42.
119. Stimson WH. Sex steroids, steroid receptors and immunity. In: Berzi I, Kovacs K, editors. Hormones and Immunity. Lancaster: MTP Press, 1987:43-53.
120. Erbach GT, Bahr JM. Enhancement of in vivo humoral immunity by estrogen:permissive effect of a thymic factor. Endocrinology 1991;128:1352-8.
121. Stimson WH, Hunter IC. Oestrogen-induced immunoregulation mediated through the thymus. J Clin Lab Immunol 1980;4: 27-33.
122. Luster MI, Hayes HT, Korach K, Tucker AN, Dean JH, Greenlee WF, et al. Estrogen immunosuppression is regulated through estrogenic responses in the thymus. J Immunol 1984; 133:110-6.
123. Matsushita I, Matsuno H, Kadowaki KM, Nakazawa F, Okada C, Tsuji M. Immunosuppressive effects of 17β-oestradiol on collagen-induced arthritis in mice. Int J Immunother 1993; IX:189-97.
124. Ansar Ahmed S, Young PR, Pennale WJ. The effects of female sex steroids on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Agents Actions 1983;54: 351-8.
125. + T lymphocytes. Scand J Immunol 1989;30:741-7.
126. Holmdahl R, Junsson L. Estrogen induced suppression of collagen arthritis. III. Adult thymectomy does not affect the course of arthritis or the estrogen mediated suppression of T cell immunity. Brain Behav Immun 1988;2:123-32.
127. Ansar Ahmed S, Dauphinée MJ, Talal N. Effects of short-term administration of sex hormones on normal and autoimmune mice. J Immunol 1985;134:204-10.
128. Ho P-C, Tang GWK, Lawton JWM. Lymphocyte subsets in patients with oestrogen deficiency. J Reprod Immunol 1991: 85-91.
129. Tada Y, Ho A, Koh DR, Mak TW. Collagen-induced arthritis in CD4-or CDK-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996;156:4520-6.
130. Mosmann TR, Coffrnan RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
131. Aranco B, Dowell T, Diegel M, Daynes R. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T-cells. Blood 1992;78:688-99.
132. Wang Y, Campbell HD, Young IG. Sex hormones and dexamethasone modulate interleukin-5 gene expression in T lymphocytes. J Steroid Biochem Mol Biol 1993;44:203-10.
133. Fox HS, Bond BL, Parslow TG, Estrogen regulates the IFN-γ promotor. J Immunol 1991;146:4362-7.
134. Barañao RI, Tenenbaum A, Rumi LS. Effects of sexual steroid hormones on the functionality of murine peritoneal macrophages. Steroids 1991;56:481-5.
135. Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142:67-78.
136. Vicari AP, Zlotnik A. Mouse NK1.1+ T cells: A new family of T cells. Immunol Today 1996;17:71-6.
137. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997;6:469-77.
138. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997;186: 1677-87.
139. Seaman WE, Gindhart TD. Effect of estrogen on natural killer cells. Arthritis Rheum 1979;22:1234-40.
140. Stern K, Davidsohn I. Effect of estrogen and cortisone on immune hemoantibodies in mice of inbred strains. J Immunol 1955;74:479-84.
141. Baines MG, Pross HF. Impairment of the thymus-dependent humoral immune response by syngeneic or allogeneic pregnancy. J Reprod Immunol 1982;4:337-48.
142. Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum 1986;29:174-84.
143. Pereira RS, Black CM, Duanee VC, Jones VE, Jacoby RK, Welsh KI. Disappearing collagen antibodies in rheumatoid arthritis. Lancet 1985;2:501-2.
144. Link H, Baig S, Olsson O, Yu-Ping J, Höjeherg B, Olsson T. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 1990; 28:237.
145. Jansson L, Holmdahl R. Genes on the X chromosome affect the development of collagen induced arthritis in mice. Clin Exp Immunol 1993;94:459-65.
146. Holmdahl R. Estrogen exaggerates lupus but suppresses T-cell-dependent autoimmune disease. J Autoimmun 1989;2:651-6.
147. Waksman Y, Hod I, Friedman A. Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII). Clin Exp Immunol 1996;103:376-83.
148. Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B-lymphopoiesis. Proc Natl Acad Sci USA 1994;91:5382-6.
149. Kincade PW, Medina KL, Smithson G. Sex hormones as negative regulators of lymphopoiesis. Immunol Reviews 1994; 137:119-134.
150. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-5.
151. Poli V, Balena R, Fattori E, Markalos A, Yamamoto M, Tanaka H, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13:1189-96.
152. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
153. Cutolo M, Seriolo B, De Cesari F, Accardo S. Sex hormones and rheumatic diseases. In: Bálint G, editor. Rheumatology, State of the Art. Amsterdam: Elsevier 1992;148-52.
154. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in post menopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 1995;88:902-6.
155. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, et al. Raloxifene (LY139481 HCl) prevents hone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 1994;93:63-9.
156. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, et al. Estrogen inhibits bone resorption by directly inducing apoplosis of the bone-resorbing osteoclasts. J Exp Med 1997;186:489-95.
157. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effect. Science 1993;260:626-7.
158. Mundy GR. Immune system and hone remodeling. Trends Endocrin Metabol 1990;July/August:307-11.
159. Shingu M, Nagai Y, Isayama T, Naono T, Nobunga M, Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 1993;94:145-49.
160. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: Structure and functions. Endocrine Rev 1990; 11: 201-20.
161. Bealo M. Gene regulation by steroid hormones. Cell 1989;56: 335-44.
162. Morimoto RI. Heat shock: The role of transient inducible responses in cell damage, transformation, and differentiation. Cancer Cells 1991;3:295-301.
163. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function hut not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993;90: 11162-6.
164. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, et al. A role for oestrogens in the male reproductive system. Nature 1997;390:509-12.
165. Ogawa S, Lubahn DB, Korach KS, Pfaff DW. Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci USA 1997;94:1476-81.
166. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30.
167. Kuiper GG, Carlsson B, Grandien K, Enmark E, Hagghlad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
168. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997;11:1486-96.
169. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science 1996; 273:1222-5.
170. Clark JH, Markaverich BM. The agonistic and antagonistic actions of estriol. J Steroid Biochem 1984;20:1005-13.
171. Batra S, Björk P, Sjögren C. Binding of estradiol-17β and estriol in cytosolic and nuclear fractions from urogenital tissues. J Steroid Biochem 1984;21:163-8.
172. Sasson S, Notides AC. The estriol-induced inhibition of the estrogen receptor's positive cooperativity. J Steroid Biochem 1984;20:1021-6.
173. Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol 1996;10:230-42.
174. Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, et al. Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 1991;19:111-7.
175. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. [published erratum appears in N Engl J Med 1995;332:131]. N Engl J Med 1994;331: 1056-61.
176. Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 1991;51: 3867-73.
177. Carlsten H, Holmdahl R, Tarkowski A, Nilsson LA. Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology 1989;67:205-9.